http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2491331-C1
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5160388b652e0db4292b7cef4b317ba6 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A23L33-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-74 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N1-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A23C9-12 |
filingDate | 2012-05-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 2013-08-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a3f8f1671de0131fd482ef429ef6a9df http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_570af51be0e1947621bcad363e48a49e http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2ae11fdffb9d8aba5065b4e8e17cbe00 |
publicationDate | 2013-08-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | RU-2491331-C1 |
titleOfInvention | Bifidobacterial and lactobacillary consortium for preparing bacterial preparations and dietary supplements for correcting gastrointestinal microflora in children under age of three, and method for preparing it, dietary supplement and bacterial preparation for treating dysbiotic gastrointestinal conditions in children under age of three |
abstract | FIELD: medicine, pharmaceutics. n SUBSTANCE: bifidobacterial and lactobacillary consortium contains Bifidobacterium bifidum OV-19, B.bifidum 791, B.longum B379M, B.breve OV-12, B.infantis 73-15, Lactobacillus helveticus "К3ш24", L.helveticus NK-11, L.casei KHM-12; it is used for preparing bacterial preparations, as a part of dietary supplements for correcting the microflora in the children under the age of three. The consortium is high-technology; it stores a biomass on nutrient mediums over a short period of time with a high concentration of probiotic microorganisms, possesses the acid-forming and antagonist properties in relation to the pathogenic and opportunistic microflora. The consortium is prepared by the co-culture of the strains including the length of an exponential growth phase of each of them. Thereby a priority of the nutrient medium inoculation of the specific composition is determined. n EFFECT: using the consortium as a part of the bacterial preparation for treating the dysbiotic gastrointestinal conditions in the children, and the dietary supplements, provides the more effective and fast correction of the child's gastrointestinal microflora. n 4 cl, 10 tbl, 3 ex |
isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2752891-C1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2022154692-A1 |
priorityDate | 2012-05-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 796.